Clinical Trial

Effect of Watermelon on Cardiometabolic Health

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine whether consumption of 355 ml of watermelon juice will: 1. improve cardiovascular and overall metabolic health markers like blood pressure, heart rate, stiffness/flexibility of arteries (blood vessels), blood sugar, cholesterol), and gut hormones 2. contribute to the body's ability to protect itself from the potential cell damage caused by harmful chemical compounds (produced when skin is exposed to ultraviolet (UV) B light, for example). This will be evaluated by measuring how resistant skin is to the damage from UVB light exposure, as well as several markers of bodily stress blood and urine. This will be determined immediately after consuming the juice (to evaluate the effects the juice has on health right away), as well as after 4 weeks of daily juice consumption (to evaluate the effects the juice has on health when consumed consistently over time).
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-01
Trial Details
NCT Number NCT07006636
Lead Sponsor University of California, Los Angeles
Collaborators: National Watermelon Promotion Board
Conditions Cardiometabolic Health Indicators, Whole-body Antioxidant Capacity
Enrollment 22 participants
Start Date 2026-04-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-31